Amerisourcebergen Corp (ABC) Files Form 4 Insider Selling : Henry Wadsworth Iii Mcgee Sells 3,351 Shares

Amerisourcebergen Corp (ABC): Henry Wadsworth Iii Mcgee , director of Amerisourcebergen Corp sold 3,351 shares on Sep 21, 2016. The Insider selling transaction was reported by the company on Sep 22, 2016 to the Securities and Exchange Commission. The shares were sold at $82.10 per share for a total value of $275,117.09 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 8, 2016, Kathy H. Gaddes (Executive Vice President) sold 681 shares at $88.15 per share price.On Sep 1, 2016, John G. Chou (Executive Vice President) sold 63,750 shares at $85.70 per share price.Also, On Aug 10, 2016, Lon R Greenberg (director) purchased 4,000 shares at $88.59 per share price.On Aug 9, 2016, Robert P. Mauch (Executive Vice President) sold 24,178 shares at $89.90 per share price.

Shares of AmerisourceBergen Corp. (ABC) ended Tuesday, Sep 21, 2016 session in red amid volatile trading. The shares closed down -1.18 points or -1.42% at $82.08 with 24,84,426 shares getting traded. Post opening the session at $83.65, the shares hit an intraday low of $82.07 and an intraday high of $83.68 and the price vacillated in this range throughout the day. The company has a market cap of $17,625 M and the number of outstanding shares has been calculated to be 21,47,34,260 shares. The 52-week high of AmerisourceBergen Corp. is $107.36 and the 52-week low is $73.31.

AmerisourceBergen Corp. Money Flow Index Chart

Company has been under the radar of several Street Analysts.AmerisourceBergen Corp. is Reiterated by Mizuho to Neutral and the brokerage firm has raised the Price Target to $ 90 from a previous price target of $80 .The Rating was issued on Aug 11, 2016.AmerisourceBergen Corp. is Reiterated by FBR Capital to Mkt Perform and the brokerage firm has raised the Price Target to $ 90 from a previous price target of $84 .The Rating was issued on Aug 3, 2016.AmerisourceBergen Corp. is Reiterated by Barclays to Equal Weight and the brokerage firm has raised the Price Target to $ 89 from a previous price target of $83 .The Rating was issued on Aug 3, 2016.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.